0001419612--12-31Q1falseRepresents an amount less than $1. 0001419612 2023-01-01 2023-03-31 0001419612us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001419612us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001419612sedg:ShortTermCorporateBondsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001419612sedg:ShortTermCorporateBondsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001419612sedg:ShortTermGovernmentalBondsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001419612sedg:ShortTermGovernmentalBondsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001419612sedg:LongTermCorporateBondsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001419612sedg:LongTermCorporateBondsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001419612sedg:LongTermGovernmentalBondsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001419612sedg:LongTermGovernmentalBondsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001419612us-gaap:FairValueInputsLevel2Memberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001419612us-gaap:FairValueInputsLevel2Memberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001419612us-gaap:DerivativeFinancialInstrumentsAssetsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001419612us-gaap:DerivativeFinancialInstrumentsAssetsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001419612us-gaap:CashMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001419612us-gaap:CashMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001419612us-gaap:DepositsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001419612us-gaap:DepositsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001419612 2022-01-01 2022-03-31 0001419612us-gaap:CorporateDebtSecuritiesMember 2023-03-31 0001419612us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2023-03-31 0001419612 2023-03-31 0001419612us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001419612us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2022-12-31 0001419612 2022-12-31 0001419612 2023-05-01 0001419612us-gaap:ConvertibleDebtMember 2020-09-25 0001419612us-gaap:ConvertibleDebtMember 2020-09-01 2020-09-25 0001419612sedg:ConvertibleSeniorNotesMember 2023-03-31 0001419612sedg:ConvertibleSeniorNotesMember 2022-12-31 0001419612us-gaap:ConvertibleDebtMember 2023-01-01 2023-03-31 0001419612us-gaap:ConvertibleDebtMember 2023-03-31 0001419612us-gaap:FairValueInputsLevel2Memberus-gaap:SeniorNotesMember 2023-03-31 0001419612us-gaap:ConvertibleDebtMember 2022-01-01 2022-03-31 0001419612 2021-12-31 0001419612 2022-03-31 0001419612currency:ILSus-gaap:ForeignExchangeForwardMemberus-gaap:PutOptionMember 2023-03-31 0001419612currency:ILSus-gaap:ForeignExchangeForwardMemberus-gaap:CallOptionMember 2023-03-31 0001419612us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0001419612us-gaap:DesignatedAsHedgingInstrumentMember 2023-03-31 0001419612us-gaap:NondesignatedMember 2022-01-01 2022-03-31 0001419612us-gaap:NondesignatedMember 2023-01-01 2023-03-31 0001419612us-gaap:DesignatedAsHedgingInstrumentMember 2022-01-01 2022-03-31 0001419612us-gaap:DesignatedAsHedgingInstrumentMember 2023-01-01 2023-03-31 0001419612sedg:OfficeRentLeaseAgreementsMember 2023-03-31 0001419612sedg:ProjectsWithCustomersMember 2023-03-31 0001419612us-gaap:PatentsMember 2023-01-01 2023-03-31 0001419612us-gaap:CommonStockMember 2021-12-31 0001419612us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001419612us-gaap:RetainedEarningsMember 2021-12-31 0001419612us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001419612us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001419612us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001419612us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001419612us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001419612us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001419612us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001419612us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001419612us-gaap:RetainedEarningsMember 2022-12-31 0001419612us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001419612us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001419612us-gaap:CommonStockMember 2022-12-31 0001419612us-gaap:RetainedEarningsMember 2023-03-31 0001419612us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001419612us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001419612us-gaap:CommonStockMember 2023-03-31 0001419612us-gaap:RetainedEarningsMember 2022-03-31 0001419612us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001419612us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001419612us-gaap:CommonStockMember 2022-03-31 0001419612us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001419612sedg:DeferredRevenueYearOneMember 2023-03-31 0001419612sedg:DeferredRevenueYearTwoMember 2023-03-31 0001419612sedg:DeferredRevenueYearThreeMember 2023-03-31 0001419612sedg:DeferredRevenueYearFourMember 2023-03-31 0001419612sedg:DeferredRevenueYearFiveMember 2023-03-31 0001419612sedg:DeferredRevenueYearFiveThereafterMember 2023-03-31 0001419612us-gaap:AvailableforsaleSecuritiesMember 2022-01-01 2022-03-31 0001419612us-gaap:AvailableforsaleSecuritiesMember 2023-01-01 2023-03-31 0001419612us-gaap:AvailableforsaleSecuritiesMember 2022-03-31 0001419612us-gaap:AvailableforsaleSecuritiesMember 2023-03-31 0001419612us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2021-12-31 0001419612us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2023-01-01 2023-03-31 0001419612us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-01-01 2022-03-31 0001419612us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-03-31 0001419612us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2023-03-31 0001419612sedg:AccumulatedTranslationAdjustmentOnIntraEntityTransactionsLongTermInvestmentNatureMember 2022-12-31 0001419612sedg:AccumulatedTranslationAdjustmentOnIntraEntityTransactionsLongTermInvestmentNatureMember 2022-01-01 2022-03-31 0001419612sedg:AccumulatedTranslationAdjustmentOnIntraEntityTransactionsLongTermInvestmentNatureMember 2023-01-01 2023-03-31 0001419612sedg:AccumulatedTranslationAdjustmentOnIntraEntityTransactionsLongTermInvestmentNatureMember 2022-03-31 0001419612sedg:AccumulatedTranslationAdjustmentOnIntraEntityTransactionsLongTermInvestmentNatureMember 2023-03-31 0001419612us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001419612us-gaap:AccumulatedTranslationAdjustmentMember 2022-01-01 2022-03-31 0001419612us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-03-31 0001419612us-gaap:AccumulatedTranslationAdjustmentMember 2022-03-31 0001419612us-gaap:AccumulatedTranslationAdjustmentMember 2023-03-31 0001419612us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-01-01 2023-03-31 0001419612us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-03-31 0001419612us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-01-01 2022-03-31 0001419612us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-01-01 2022-03-31 0001419612us-gaap:AvailableforsaleSecuritiesMember 2022-12-31 0001419612us-gaap:AvailableforsaleSecuritiesMember 2021-12-31 0001419612us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2022-12-31 0001419612sedg:AccumulatedTranslationAdjustmentOnIntraEntityTransactionsLongTermInvestmentNatureMember 2021-12-31 0001419612us-gaap:AccumulatedTranslationAdjustmentMember 2021-12-31 0001419612sedg:EmployeesAndMembersOfBoardOfDirectorsMemberus-gaap:EmployeeStockOptionMember 2022-12-31 0001419612sedg:EmployeesAndMembersOfBoardOfDirectorsMemberus-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001419612sedg:EmployeesAndMembersOfBoardOfDirectorsMemberus-gaap:EmployeeStockOptionMember 2023-01-01 2023-03-31 0001419612sedg:EmployeesAndMembersOfBoardOfDirectorsMemberus-gaap:EmployeeStockOptionMember 2023-03-31 0001419612us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001419612us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-03-31 0001419612us-gaap:RestrictedStockUnitsRSUMember 2023-03-31 0001419612us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-03-31 0001419612us-gaap:SellingAndMarketingExpenseMember 2022-01-01 2022-03-31 0001419612us-gaap:GeneralAndAdministrativeExpenseMember 2022-01-01 2022-03-31 0001419612us-gaap:IPOMember 2022-03-01 2022-03-17 0001419612us-gaap:IPOMember 2022-03-17 0001419612us-gaap:IPOMembersedg:UnderwritingAgreementMember 2022-03-01 2022-03-17 0001419612us-gaap:EmployeeStockOptionMembersedg:TwoThousandFifteenGlobalIncentivePlanMember 2023-01-01 2023-03-31 0001419612us-gaap:PhantomShareUnitsPSUsMember 2022-12-31 0001419612us-gaap:PhantomShareUnitsPSUsMember 2023-01-01 2023-03-31 0001419612us-gaap:PhantomShareUnitsPSUsMember 2023-03-31 0001419612sedg:EmployeeStockPurchasePlanMember 2023-01-01 2023-03-31 0001419612us-gaap:CostOfSalesMember 2022-01-01 2022-03-31 0001419612us-gaap:EmployeeStockOptionMembersedg:TwoThousandFifteenGlobalIncentivePlanMember 2015-03-31 0001419612us-gaap:EmployeeStockOptionMembersedg:TwoThousandSevenGlobalIncentivePlanMember 2023-03-31 0001419612sedg:EmployeeStockPurchasePlanMember 2023-03-31 0001419612us-gaap:CostOfSalesMember 2023-01-01 2023-03-31 0001419612us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-03-31 0001419612us-gaap:SellingAndMarketingExpenseMember 2023-01-01 2023-03-31 0001419612us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-03-31 0001419612us-gaap:EmployeeStockOptionMembersedg:TwoThousandFifteenGlobalIncentivePlanMember 2023-03-31 0001419612sedg:AllOtherMember 2022-01-01 2022-03-31 0001419612sedg:SolarMember 2022-01-01 2022-03-31 0001419612sedg:AllOtherMember 2023-01-01 2023-03-31 0001419612sedg:SolarMember 2023-01-01 2023-03-31 0001419612sedg:SolarSegmentRevenuesMember 2022-01-01 2022-03-31 0001419612sedg:SolarSegmentRevenuesMember 2023-01-01 2023-03-31 0001419612sedg:AllOtherSegmentRevenuesMember 2022-01-01 2022-03-31 0001419612sedg:AllOtherSegmentRevenuesMember 2023-01-01 2023-03-31 0001419612sedg:RevenuesFromServicesSc606Member 2022-01-01 2022-03-31 0001419612sedg:RevenuesFromServicesSc606Member 2023-01-01 2023-03-31 0001419612us-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMember 2023-01-01 2023-03-31 0001419612us-gaap:AccountsPayableMemberus-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-12-31 0001419612us-gaap:SubsequentEventMembersedg:HarkSystemsLimitedMember 2023-04-06 iso4217:EUR xbrli:shares iso4217:USDxbrli:shares iso4217:ILS xbrli:pure iso4217:USD



UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
WASHINGTON, D.C. 20549
 
FORM 10-Q
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended March 31, 2023
 
OR
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from _________ to __________
 
Commission File Number: 001-36894
 
SOLAREDGE TECHNOLOGIES, INC.
 
(Exact name of registrant as specified in its charter)
 
Delaware
 
20-5338862
(State or other jurisdiction of
incorporation or organization)
 
(IRS Employer
Identification No.)
 
 
1 HaMada Street
Herziliya Pituach, 4673335, Israel
(Address of Principal Executive Offices, zip code)
 
972 (9) 957-6620
 
Registrant’s telephone number, including area code
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, par value $0.0001 per share
SEDG
NASDAQ (Global Select Market)
 
Securities registered pursuant to Section 12(g) of the Act: None
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
 
  Yes ☒       No 
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
 
  Yes  ☒       No 
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller Reporting Company
   
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
Indicate by checkmark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
 
Yes        No 
 

As of May 1, 2023, there were 56,344,727 shares of the registrant’s common stock, par value of $0.0001 per share, outstanding.

 


TABLE OF CONTENTS
 
 
F-1
F-1
F-3
F-4
F-5
F-6
F-8
3
14
15
  
 
16
16
16
16
16
16
17
17
 
2

PART I. FINANCIAL INFORMATION
 
ITEM 1. FINANCIAL STATEMENTS
 

SOLAREDGE TECHNOLOGIES INC.

 
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
 
(in thousands, except per share data)
 
   
March 31,
2023
   
December 31,
2022
 
ASSETS
           
CURRENT ASSETS:
           
Cash and cash equivalents
 
$
727,849
   
$
783,112
 
Marketable securities
   
410,820
     
241,117
 
Trade receivables, net of allowances of $4,422 and $3,202, respectively
   
969,543
     
905,146
 
Inventories, net
   

874,212

     
729,201
 
Prepaid expenses and other current assets
   

259,642

     
241,082
 
Total current assets
   

3,242,066

     
2,899,658
 
LONG-TERM ASSETS:
                 
Marketable securities
   
509,127
     
645,491
 
Deferred tax assets, net
   

46,612

     
44,153
 
Property, plant and equipment, net
   
556,138
     
543,969
 
Operating lease right-of-use assets, net
   
69,710
     
62,754
 
Intangible assets, net
   
17,933
     
19,929
 
Goodwill
   

29,934

     
31,189
 
Other long-term assets
   
24,906
     
18,806
 
Total long-term assets
   

1,254,360

     
1,366,291
 
Total assets
 
$

4,496,426

   
$
4,265,949
 
 
The accompanying notes are an integral part of the condensed consolidated financial statements.
 

F -  1


 

SOLAREDGE TECHNOLOGIES INC.
 
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Cont.)
 
(in thousands, except per share data)
 
   
March 31,
2023
   
December 31,
2022
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
           
CURRENT LIABILITIES:
           
Trade payables, net
 
$

408,523

   
$
459,831
 
Employees and payroll accruals
   
90,853
     
85,158
 
Warranty obligations
   
129,278
     
103,975
 
Deferred revenues and customers advances
   
27,507
     
26,641
 
Accrued expenses and other current liabilities
   

243,881

     
214,112
 
Total current liabilities
   

900,042

     
889,717
 
LONG-TERM LIABILITIES:
               
Convertible senior notes, net
   
625,182
     
624,451
 
Warranty obligations
   
313,693
     
281,082
 
Deferred revenues
   
196,917
     
186,936
 
Finance lease liabilities
   
43,711
     
45,385
 
Operating lease liabilities
   
50,855
     
46,256
 
Other long-term liabilities
   

15,232

     
15,756
 
Total long-term liabilities
   

1,245,590

     
1,199,866
 
COMMITMENTS AND CONTINGENT LIABILITIES
           
STOCKHOLDERS’ EQUITY:
               
Common stock of $0.0001 par value - Authorized: 125,000,000 shares as of March 31, 2023 and December 31, 2022; issued and outstanding: 56,343,164 and 56,133,404 shares as of March 31, 2023 and December 31, 2022, respectively
   
6
     
6
 
Additional paid-in capital
   
1,545,777
     
1,505,632
 
Accumulated other comprehensive loss
   

(77,204

)
   

(73,109

)
Retained earnings
   

882,215

     
743,837
 
Total stockholders’ equity
   

2,350,794

     
2,176,366
 
Total liabilities and stockholders’ equity
 
$

4,496,426

   
$
4,265,949
 
 
The accompanying notes are an integral part of the condensed consolidated financial statements.

 

F -  2


 

SOLAREDGE TECHNOLOGIES INC.
 
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited)
 
(in thousands, except per share data)
 
   
Three Months Ended
March 31,
 
   
2023
   
2022
 
Revenues
 
$
943,889
   
$
655,080
 
Cost of revenues
   
643,763
     
476,122
 
Gross profit
   
300,126
     
178,958
 
Operating expenses:
               
Research and development
   
79,873
     
66,349
 
Sales and marketing
   
40,966
     
35,316
 
General and administrative
   
36,567
     
26,429
 
Other operating income, net
   
(1,434
)    
-
 
Total operating expenses
   
155,972
     
128,094
 
Operating income
   
144,154
     
50,864
 
Financial income (expense), net
   
23,674
 
   
(4,605
)

Other loss

    (125 )     (844 )
Income before income taxes
   
167,703
     
45,415
 
Income taxes
   

29,325

     
12,292
 
Net income
 
$

138,378

   
$
33,123
 
Net basic earnings per share of common stock
 
$

2.46

   
$
0.62
 
Net diluted earnings per share of common stock
 
$

2.35

   
$
0.60
 
Weighted average number of shares used in computing net basic earnings per share of common stock
   
56,215,490
     
53,134,937
 
Weighted average number of shares used in computing net diluted earnings per share of common stock
   
59,193,831
     
56,315,193
 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

F -  3


 

SOLAREDGE TECHNOLOGIES INC.
 
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
 
(in thousands, except per share data)
 
   
Three Months Ended

March 31,

 
   
2023
   
2022
 
Net income
 
$

138,378

   
$
33,123
 
Other comprehensive income (loss), net of tax:
               
Available-for-sale marketable securities
   

6,177

 
   
(9,506
)
Cash flow hedges
   

(331

)
   
(680
)
Foreign currency translation adjustments on intra-entity transactions that are of a long-term investment nature
   
(10,800
)
   
(6,983
)
Foreign currency translation adjustments
   
859
 
   
(1,579
)
Total other comprehensive loss
   

(4,095

)
   
(18,748
)
Comprehensive income
 
$

134,283

 
 
$
14,375
 

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

F -  4


 

SOLAREDGE TECHNOLOGIES INC.
 
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited)
 
(in thousands, except per share data)
 
   
Common stock
   
Additional paid in
Capital
   
Accumulated
other comprehensive
loss
     
Retained earnings
   
Total
 
   
Number
   
Amount
                 
Balance as of January 1, 2023
   
56,133,404
   
$
6
   
$
1,505,632
   
$
(73,109
)
 
$
743,837
   
$
2,176,366
 
Issuance of common stock upon exercise of stock-based awards
   
209,760
     
*-
     
75
     
-
     
-
     
75
 
Stock based compensation
   
-
     
-
     
40,070
     
-
     
-
     
40,070
 
Other comprehensive loss adjustments
   
-
     
-
     
-
     
(4,095
)
   
-
     
(4,095
)
Net income
   
-
     
-
     
-
     
-
     
138,378
     
138,378
 
Balance as of March 31, 2023
 
$
56,343,164
   
$
6
   
$
1,545,777
   
$
(77,204
)
 
$
882,215
   
$
2,350,794
 
 
* Represents an amount less than $1.
 
   
Common stock
   
Additional paid in
Capital
   
Accumulated
other comprehensive
income (loss)
     
Retained earnings
   
Total
 
   
Number
   
Amount
                 
Balance as of January 1, 2022
   
52,815,395
   
$
5
   
$
687,295
   
$
(27,319
)
 
$
650,058
   
$
1,310,039
 
Issuance of common stock upon exercise of stock-based awards
   
270,751
     
*-
     
1,478
     
-
     
-
     
1,478
 
Stock based compensation
   
-
     
-
     
34,107
     
-
     
-
     
34,107
 
Issuance of common stock in a secondary public offering, net of underwriters' discounts and commissions of $27,140 and $834 of offering costs
   
2,300,000
     
1
     
650,525
     
-
     
-
     
650,526
 
Other comprehensive loss adjustments
   
-
     
-
     
-
     
(18,748
)
   
-
     
(18,748
)
Net income
   
-
     
-
     
-
     
-
     
33,123
     
33,123
 
Balance as of March 31, 2022
   
55,386,146
   
$
6
   
$
1,373,405
   
$
(46,067
)
 
$
683,181
   
$
2,010,525
 
 
* Represents an amount less than $1.
 
The accompanying notes are an integral part of the condensed consolidated financial statements.

 

F -  5


 

SOLAREDGE TECHNOLOGIES INC.

 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
 
(in thousands, except per share data)
 
   
Three Months Ended
March 31,
 
   
2023
   
2022
 
Cash flows from operating activities:
           
Net income
 
$
138,378
   
$
33,123
 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
               
Depreciation and amortization
   
13,464
     
11,660
 
Stock-based compensation expenses
   
39,235
     
34,107
 
Deferred income taxes, net
   
(3,930
)
   
(1,034
)
Loss (gain) from exchange rate fluctuations
   
(20,441
)
   
1,725
 
Other items
   
2,810
     
4,167
 
Changes in assets and liabilities:
               
Inventories, net
   
(141,521
)
   
(51,323
)
Prepaid expenses and other assets
   
(20,591
)
   
(17,163
)
Trade receivables, net
   
(55,002
)
   
(224,865
)
Trade payables, net
   
(50,410
)
   
(28,045
)
Employees and payroll accruals
   
10,227
     
9,246
 
Warranty obligations
   
57,864
     
27,629
 
Deferred revenues and customers advances
   
9,325
     
15,029
 
Accrued expenses and other liabilities, net
   
28,515
     
22,755
 
Net cash provided by (used in) operating activities
   
7,923
     
(162,989
)
Cash flows from investing activities:
               
Proceed from sales and maturities of available-for-sale marketable securities
   
11,597
     
53,096
 
Purchase of property, plant and equipment
   
(38,338
)
   
(43,210
)
Investment in available-for-sale marketable securities
   
(38,979
)
   
(26,712
)
Investment in a privately-held company
   
(5,500
)
   
-
 
Other investing activities
   
3,440
     
1,692
 
Net cash used in investing activities
 
$
(67,780
)
 
$
(15,134
)
 
The accompanying notes are an integral part of the condensed consolidated financial statements.

 

F -  6


 

SOLAREDGE TECHNOLOGIES INC.
 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (Cont.)
 
(in thousands, except per share data)
 
   
Three Months Ended
March 31,
 
   
2023
   
2022
 
Cash flows from financing activities:
           
Proceeds from secondary public offering, net of issuance costs
 
$
-
   
$
650,526
 
Proceeds from exercise of stock-based awards
   
75
     
1,478
 
Tax withholding in connection with stock-based awards, net
   
(4,541
)
   
822
 
Other financing activities
   
(756
)
   
(491
)
Net cash provided by (used in) financing activities
   
(5,222
)
   
652,335
 
Increase (decrease) in cash and cash equivalents
   
(65,079
)
   
474,212
 
Cash and cash equivalents at the beginning of the period
   
783,112
     
530,089
 
Effect of exchange rate differences on cash and cash equivalents
   
9,816
     
(1,529
)
Cash and cash equivalents at the end of the period
 
$
727,849
   
$
1,002,772
 
                 
Supplemental disclosure of non-cash activities:
               
Right-of-use asset recognized with a corresponding lease liability
 
$
11,258
   
$
27,248
 
Purchase of property, plant and equipment
 
$
12,304
   
$
19,536
 
 
The accompanying notes are an integral part of the condensed consolidated financial statements.
 

 F - 7


 
SOLAREDGE TECHNOLOGIES INC.
 
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
 

(in thousands, except per share data)

 

NOTE 1:      GENERAL
 
  a.
SolarEdge Technologies, Inc. (the “Company”) and its subsidiaries design, develop, and sell an intelligent inverter solution designed to maximize power generation at the individual photovoltaic (“PV”) module level while lowering the cost of energy produced by the solar PV system and providing comprehensive and advanced safety features. The Company’s products consist mainly of (i) power optimizers designed to maximize energy throughput from each and every module through constant tracking of Maximum Power Point individually per module, (ii) inverters which invert direct current (DC) from the PV module to alternating current (AC) including the Company’s Energy Hub inverter which supports, among other things, connection to a DC-coupled battery for full or partial home backup, and optional connection to the Company's smart EV charger, (iii) a remote cloud-based monitoring platform, that collects and processes information from the power optimizers and inverters to enable customers and system owners, to monitor and manage the solar PV system (iv) a residential storage and backup solution which includes a company designed and manufactured lithium-ion DC-coupled battery that is used to increase energy independence and maximize self-consumption for homeowners including a battery, and (v) additional smart energy management solutions.
 
The Company and its subsidiaries sell products worldwide through large distributors, electrical equipment wholesalers, as well as directly to large solar installers and engineering, procurement, and construction firms.
 
  b.
The Company has expanded its activity to other areas of smart energy technology organically and through acquisitions. The Company now offers a variety of energy solutions, which include lithium-ion cells, batteries, and energy storage systems (“Energy Storage”), full powertrain kits for electric vehicles, or EVs (“e-Mobility”), as well as automated machines for industrial use (“Automation Machines”).
 
  c.
Basis of Presentation:
 
The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). In management’s opinion, the unaudited condensed consolidated financial statements reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the interim periods presented. The Company’s interim period results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year.
 
The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2022, contained in the Company’s Annual Report on Form 10-K filed with the SEC on February 22, 2023, have been applied consistently in these unaudited interim condensed consolidated financial statements. Certain prior year amounts have been reclassified to conform to current year presentation.
 
  d.
Use of estimates:
 
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures in the accompanying notes. The duration, scope and effects of the ongoing Covid-19 pandemic and the conflict in Ukraine, government and other third-party responses to it, and the related macroeconomic effects, including to the Company’s business and the business of the Company’s suppliers and customers are uncertain, rapidly changing and difficult to predict. As a result, the Company’s accounting estimates and assumptions may change over time in response to this evolving situation. Such changes could result in future impairments of goodwill, intangibles, long-lived assets, inventories, incremental credit losses on receivables and available-for-sale marketable debt securities, or an increase in the Company’s insurance liabilities as of the time of a relevant measurement event.
 
  e.
Concentrations of supply risks:
 
The Company depends on two contract manufacturers and several limited or single source component suppliers. Reliance on these vendors makes the Company vulnerable to possible capacity constraints and reduced control over component availability, delivery schedules, manufacturing yields, and costs.
 
As of March 31, 2023, and December 31, 2022, two contract manufacturers collectively accounted for 31.3% and 34.3% of the Company’s total trade payables, net, respectively.
 
In the second quarter of 2022, the Company announced the opening of “Sella 2”, a two gigawatt-hour (GWh) Li-Ion battery cell manufacturing facility located in South Korea. Sella 2 began producing and shipping cells at the end of 2022 and is expected to reach full manufacturing capacity in 2023. Sella 2 is the Company's second owned manufacturing facility following the establishment of Sella 1 in 2020. Sella 1 is the Company's manufacturing facility in the North of Israel that produces power optimizers and inverters for the Company's solar activities.
 
  f.
New accounting standards updates:
 
From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board ("FASB") or other standard setting bodies are adopted by the Company as of the specified effective date. The Company believes that the impact of recently issued or newly effective standards were not applicable to the Company, did not have a material impact on the condensed consolidated financial statements or are not expected to have a material impact on the condensed consolidated financial statements.

 

F - 8


SOLAREDGE TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

 

(in thousands, except per share data)

 

NOTE 2:       MARKETABLE SECURITIES
 
The following is a summary of available-for-sale marketable securities as of March 31, 2023:
 
   
Amortized
cost
   
Gross unrealized
gains
   
Gross unrealized
losses
   
Fair value
 
Available-for-sale – matures within one year:
                       
Corporate bonds
 
$
390,012
   
$
82
   
$
(8,595
)
 
$
381,499
 
Governmental bonds
   
29,788
     
-
     
(467
)
   
29,321
 
     
419,800
     
82
     
(9,062
)
   
410,820
 
Available-for-sale – matures after one year:
                               
Corporate bonds
   
515,425
     
698
     
(15,855
)
   
500,268
 
Governmental bonds
   
9,251
     
-
     
(392
)
   
8,859
 
     
524,676
     
698
     
(16,247
)
   
509,127
 
Total
 
$
944,476
   
$
780
   
$
(25,309
)
 
$
919,947
 
 
The following is a summary of available-for-sale marketable securities as of December 31, 2022:
 
   
Amortized
cost
   
Gross unrealized
gains
   
Gross unrealized
losses
   
Fair value
 
Available-for-sale – matures within one year:
                       
Corporate bonds
 
$
222,482
   
$
-
   
$
(4,657
)
 
$
217,825
 
Governmental bonds
   
23,845
     
-
     
(553
)
   
23,292
 
     
246,327
     
-
     
(5,210
)
   
241,117
 
Available-for-sale – matures after one year:
                               
Corporate bonds
   
657,238
     
80
     
(26,460
)
   
630,858
 
Governmental bonds
   
15,250
     
-
     
(617
)
   
14,633
 
     
672,488
     
80
     
(27,077
)
   
645,491
 
Total
 
$
918,815
   
$
80
   
$
(32,287
)
 
$
886,608
 
 
As of March 31, 2023, and December 31, 2022, the Company did not record an allowance for credit losses for its available-for-sale marketable securities.

 

F - 9


SOLAREDGE TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

 

(in thousands, except per share data)

 

NOTE 3:       INVENTORIES, NET
 
   

March 31,

2023

   
December 31,
2022
 
Raw materials
 
$
503,445
   
$
503,257
 
Work in process
   
37,754
     
23,407
 
Finished goods
   
333,013
     
202,537
 

Total inventories, net

 
$
874,212
   
$
729,201
 

 

NOTE 4:       PREPAID EXPENSES AND OTHER CURRENT ASSETS
 
   
March 31,
2023
   
December 31,
2022
 
Vendor non-trade receivables (*)
 
$
147,238
   
$
147,597
 
Government authorities
   
57,275
     
55,670
 
Prepaid expenses and other
   
55,129
     
37,815
 
Total prepaid expenses and other current assets
 
$
259,642
   
$
241,082
 
 
(*) Vendor non-trade receivables derived from the sale of components to manufacturing vendors who manufacture products for the Company. The Company purchases these components directly from other suppliers. The Company does not reflect the sale of these components to the contract manufacturers in its revenues.

 

F - 10


SOLAREDGE TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

 

(in thousands, except per share data)

 

NOTE 5:       DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

 
During the three months ended March 31, 2023, the Company instituted a foreign currency cash flow hedging program to reduce the risk of a forecasted increase in the value of foreign currency cash flows, resulting from payment of salaries in Israeli currency, the New Israeli Shekels (“NIS”). The Company hedges portions of the anticipated payroll denominated in NIS for a period of one to nine months with hedging contracts. These hedging contracts are designated as cash flow hedges, as defined by ASC 815 and are all effective hedges.
 
As of March 31, 2023, the Company entered into forward contracts and put and call options to sell U.S. dollars (“USD”) for NIS in the amount of approximately NIS 231 million and NIS 125 million, respectively.
 
In addition to the above-mentioned cash flow hedge transactions, the Company occasionally enters into derivative instrument arrangements to hedge the Company’s exposure to currencies other than the USD. These derivative instruments are not designated as cash flow hedges, as defined by ASC 815, and therefore all gains and losses, resulting from fair value remeasurement, were recorded immediately in the statement of income, under "Financial income (expense), net".
 
The Company classifies cash flows related to its hedging as operating activities in its condensed consolidated statement of cash flows.
 
The fair values of outstanding derivative instruments were as follows:
 
 
Balance sheet location
 
March 31,
2023
   
December 31,
2022
 
Derivative assets of options and forward contracts:
             
Designated cash flow hedges
Prepaid expenses and other current assets
 
$
353
   
$
-
 
Derivative liabilities of options and forward contracts:
                 
Designated cash flow hedges
Accrued expenses and other current liabilities
 
$
(2,583
)
 
$
(1,874
)
 
Gains (losses) on derivative instruments are summarized below:
 
     

Three Months Ended

March 31,

 
 
Affected line item
 
2023
   
2022
 
Foreign exchange contracts
             
Non Designated Hedging Instruments
Condensed Consolidated Statements of Income - Financial income (expense), net
 
$
-
   
$
934
 
Designated Hedging Instruments
Condensed Consolidated Statements of Comprehensive Income - Cash flow hedges
 
$
(2,057
)
 
$
(1,178
)
 
See Note 13 for information regarding losses from designated hedging instruments reclassified from accumulated other comprehensive loss.

 

F - 11


SOLAREDGE TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

 

(in thousands, except per share data)

 

NOTE 6:    FAIR VALUE MEASUREMENTS
 
In accordance with ASC 820, the Company measures its cash equivalents and marketable securities, at fair value using the market approach valuation technique. Cash and cash equivalents are classified within Level 1 because these assets are valued using quoted market prices. Marketable securities and foreign currency derivative contracts are classified within level 2 due to these assets being valued by alternative pricing sources and models utilizing market observable inputs.
 
The following table sets forth the Company’s assets that were measured at fair value as of March 31, 2023 and December 31, 2022, by level within the fair value hierarchy:
 
   
Fair Value Hierarchy
 
Fair value measurements as of
 
Description
   
March 31, 2023
   
December 31, 2022
 
Assets:
               
Cash and cash equivalents:
               
Cash
 
Level 1
 
$
667,384
   
$
695,004
 
Money market mutual funds
 
Level 1
 
$
17,486
   
$
25,149
 
Deposits
 
Level 1
 
$
42,979
   
$
62,959
 
Derivative instruments
 
Level 2
 
$
353
   
$
-
 
Short-term marketable securities:
                   
Corporate bonds
 
Level 2
 
$
381,499
   
$
217,825
 
Governmental bonds
 
Level 2
 
$
29,321
   
$
23,292
 
Long-term marketable securities:
                   
Corporate bonds
 
Level 2
 
$
500,268
   
$
630,858
 
Governmental bonds
 
Level 2
 
$
8,859
   
$
14,633
 
Liabilities:
                   
Derivative instruments
 
Level 2
 
$
(2,583
)
 
$
(1,874
)
 
NOTE 7:       WARRANTY OBLIGATIONS
 
Changes in the Company’s product warranty obligations for the three months ended March 31, 2023 and 2022, were as follows:
 
   
Three Months Ended March 31,
 
   
2023
   
2022
 
Balance, at the beginning of the period
 
$
385,057
   
$
265,160
 
Additions and adjustments to cost of revenues
   
91,570
     
47,907
 
Usage and current warranty expenses
   
(33,656
)
   
(20,401
)
Balance, at end of the period
   
442,971
     
292,666
 
Less current portion
   
(129,278
)
   
(82,340
)
Long term portion
 
$
313,693
   
$
210,326
 

 

F - 12


SOLAREDGE TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

 

(in thousands, except per share data)

 

NOTE 8:       DEFERRED REVENUES AND CUSTOMERS ADVANCES
 
Deferred revenues consist of deferred cloud-based monitoring services, communication services, warranty extension services and advance payments received from customers for the Company’s products. Deferred revenues are classified as short-term and long-term deferred revenues based on the period in which revenues are expected to be recognized.
 
Significant changes in the balances of deferred revenues and customer advances during the period are as follows:
 
   
Three Months Ended
March 31,
 
   
2023
   
2022
 
Balance, at the beginning of the period
 
$
213,577
   
$
169,345
 
Revenue recognized
   
(11,742
)
   
(14,529
)
Increase in deferred revenues and customer advances
   
22,589
     
29,429
 
Balance, at the end of the period
   
224,424
     
184,245
 
Less current portion
   
(27,507
)
   
(25,511
)
Long term portion
 
$
196,917
   
$
158,734
 
 
The following table includes estimated revenues expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) as of March 31, 2023:
 
2023
 
$
23,888
 
2024
   
12,073
 
2025
   
10,764
 
2026
   
10,389
 
2027
   
8,363
 
Thereafter
   
158,947
 
Total deferred revenues
 
$
224,424
 

 

NOTE 9:       ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
 
   
March 31,
2023
   
December 31,
2022
 
Accrued expenses
 
$
127,018
   
$
117,638
 
Government authorities
   
87,159
     
67,514
 
Operating lease liabilities
   
17,215
     
16,183
 
Accrual for sales incentives
   
5,746
     
6,790
 
Other
   
6,743
     
5,987
 
Total accrued expenses and other current liabilities
 
$
243,881
   
$
214,112
 

 

F - 13


SOLAREDGE TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

 

(in thousands, except per share data)

 

NOTE 10:       CONVERTIBLE SENIOR NOTES
 
On September 25, 2020, the Company sold $632,500 aggregate principal amount of its 0.00% convertible senior notes due 2025 (the “Notes”). The Notes were sold pursuant to an indenture, dated September 25, 2020 (the “Indenture”), between the Company and U.S. Bank National Association, as trustee. The Notes do not bear regular interest and mature on September 15, 2025, unless earlier repurchased or converted in accordance with their terms. The Notes are general senior unsecured obligations of the Company. Holders may convert their Notes prior to the close of business on the business day immediately preceding June 15, 2025 in multiples of $1,000 principal amount, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on December 31, 2020 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five-business-day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each trading day of that five consecutive trading day period was less than 98% of the product of the last reported sale price of the common stock and the conversion rate on each such trading day; or (3) upon the occurrence of specified corporate events as described in the Indenture. In addition, holders may convert their Notes, in multiples of $1,000 principal amount, at their option at any time beginning on or after June 15, 2025, and prior to the close of business on the second scheduled trading day immediately preceding the stated maturity date of the Notes, without regard to the foregoing circumstances. The initial conversion rate for the Notes was 3.5997 shares of common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $277.80 per share of common stock, subject to adjustment upon the occurrence of certain specified events as set forth in the Indenture.
 
Upon conversion, the Company may choose to pay or deliver, as the case may be, cash, shares of common stock, or a combination of cash and shares of common stock.
 
In addition, upon the occurrence of a fundamental change (as defined in the Indenture), holders of the Notes may require the Company to repurchase all or a portion of their Notes, in multiples of $1,000 principal amount, at a repurchase price of 100% of the principal amount of the Notes, plus any accrued and unpaid special interest to, but excluding the fundamental change repurchase date. If certain fundamental changes referred to as make-whole fundamental changes occur, the conversion rate for the Notes may be increased.
 

The Convertible Senior Notes consisted of the following as of March 31, 2023 and December 31, 2022:

   
March 31,
2023
   
December 31,
2022
 
Liability:
           
Principal
 
$
632,500
   
$
632,500
 
Unamortized issuance costs
   
(7,318
)
   
(8,049
)
Net carrying amount
 
$
625,182
   
$
624,451
 
 
For the three months ended March 31, 2023 and 2022 the Company recorded amortized debt issuance costs related to the Notes in the amount of $731 and $728, respectively.
 
As of March 31, 2023, the unamortized issuance costs of the Notes will be amortized over the remaining term of approximately 2.5 years.
 
The annual effective interest rate of the Notes is 0.47%.
 
As of March 31, 2023, the estimated fair value of the Notes, which the Company has classified as Level 2 financial instruments, is $823,730. The estimated fair value was determined based on the quoted bid price of the Notes in an over-the-counter market on the last trading day of the reporting period.
 
As of March 31, 2023, the if-converted value of the Notes exceeded the principal amount by $59,537.

 

F - 14


SOLAREDGE TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

 

(in thousands, except per share data)

 

NOTE 11:       STOCK CAPITAL
 
a. Common stock rights:
 
Common stock confers upon its holders the right to receive notice of, and to participate in, all general meetings of the Company, where each share of common stock shall have one vote for all purposes, to share equally, on a per share basis, in bonuses, profits, or distributions out of fund legally available therefor, and to participate in the distribution of the surplus assets of the Company in the event of liquidation of the Company.
 
b. Secondary public offering:
 
On March 17, 2022, the Company offered and sold 2,300,000 shares of the Company’s common stock, at a public offering price of $295.00 per share. The shares of Common Stock were issued and sold in a registered offering pursuant to the underwriting agreement dated March 17, 2022, among the Company, Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, and Morgan Stanley & Co. LLC (the “Underwriting Agreement”). All of the offered shares were issued at closing, including 300,000 shares of Common Stock that were issued and sold pursuant to the underwriters’ option to purchase additional shares under the Underwriting Agreement, which was exercised in full on March 18, 2022.
 
The net proceeds to the Company were $650,526 after deducting underwriters' discounts of $27,140 and commissions of $834.
 
c. Equity Incentive Plans:
 
The Company’s 2007 Global Incentive Plan (the “2007 Plan”) was adopted by the board of directors on August 30, 2007. The 2007 Plan terminated upon the Company’s IPO on March 31, 2015 and no further awards may be granted thereunder. All outstanding awards will continue to be governed by their existing terms and 379,358 available options for future grants were transferred to the Company’s 2015 Global Incentive Plan (the “2015 Plan”) and are reserved for future issuances under the 2015 plan. The 2015 Plan became effective upon the consummation of the IPO. The 2015 Plan provides for the grant of options, restricted stock units ("RSU"), performance stock units ("PSU"), and other share-based awards to directors, employees, officers, and non-employees of the Company and its subsidiaries. As of March 31, 2023, a total of 20,853,755 shares of common stock were reserved for issuance pursuant to stock awards under the 2015 Plan (the “Share Reserve”), an aggregate of 12,005,195 shares are still available for future grants.
 
The Share Reserve will automatically increase on January 1st of each year during the term of the 2015 Plan, commencing on January 1st  of the year following the year in which the 2015 Plan becomes effective, in an amount equal to 5% of the total number of shares of capital stock outstanding on December 31st of the preceding calendar year; provided, however, that the Company’s board of directors may determine that there will not be a January 1st increase in the Share Reserve in a given year or that the increase will be less than 5% of the shares of capital stock outstanding on the preceding December 31st.
 

The Company granted under its 2015 Plan, PSU awards to certain employees and officers which vest upon the achievement of certain performance or market conditions subject to their continued employment with the Company.

 

In 2021, the Company has also committed to issuing additional shares, which carry certain performance conditions (including business performance targets and a continued service relationship with the Company) and are treated as PSUs for accounting purposes.
 

The market condition for the PSUs is based on the Company’s total shareholder return ("TSR") compared to the TSR of companies listed in the S&P 500 index over a one to three year performance period. The Company uses a Monte-Carlo simulation to determine the grant date fair value for these awards, which takes into consideration the market price of a share of the Company’s common stock on the date of grant less the present value of dividends expected during the requisite service period, as well as the possible outcomes pertaining to the TSR market condition. The Company recognizes such compensation expenses on an accelerated vesting method.
 
The aggregate maximum number of shares of common stock that may be issued on the exercise of incentive stock options is 10,000,000. As of March 31, 2023, an aggregate of 8,617,974 options are still available for future grants under the 2015 Plan.

 

F - 15


SOLAREDGE TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

 

(in thousands, except per share data)

 
A summary of the activity in stock options and related information is as follows:
 
   
Number of options
   
Weighted average exercise price
   
Weighted average remaining contractual term in years
   
Aggregate intrinsic Value
 
Outstanding as of December 31, 2022
   
339,029
   
$
50.64
     
4.86
   
$
79,414
 
Exercised
   
(3,645
)
   
20.46
     
-
     
1,073
 
Outstanding as of March 31, 2023
   
335,384
   
$
50.97
     
4.63
   
$
84,989
 
Vested and expected to vest as of March 31, 2023
   
334,950
   
$
50.80
     
4.62
   
$
84,937
 
Exercisable as of March 31, 2023
   
311,240
   
$
40.47
     
4.43
   
$
82,079
 
 
The aggregate intrinsic value in the tables above represents the total intrinsic value (the difference between the fair value of the Company’s common stock as of the last day of each period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on the last day of each period.
 
A summary of the activity in the RSUs and related information is as follows:
 
   
Number of RSUs
   
Weighted average grant date fair value
 
Unvested as of December 31, 2022
   
1,488,515
   
$
232.05
 
Granted
   
103,081
     
296.64
 
Vested
   
(197,866
)
   
164.31
 
Forfeited
   
(31,296
)
   
254.24
 
Unvested as of March 31, 2023
   
1,362,434
   
$
246.27
 
 
A summary of the activity in the PSUs and related information is as follows:
 
   
Number of PSUs
   
Weighted average grant date fair value
 
Unvested as of December 31, 2022
   
149,232
   
$
295.88
 
Granted
   
31,911
     
314.22
 
Vested
   
(8,249
)
   
270.93
 
Unvested as of March 31, 2023
   
172,894
   
$
300.45
 
 
d.
Employee Stock Purchase Plan ("ESPP"):
 
The Company adopted an ESPP effective upon the consummation of the IPO. As of March 31, 2023, a total of 4,150,380 shares were reserved for issuance under this plan. The number of shares of common stock reserved for issuance under the ESPP will increase automatically on January 1st of each year, for ten years, by the lesser of 1% of the total number of shares of the Company’s common stock outstanding on December 31st of the preceding calendar year or 487,643 shares. However, the Company’s board of directors may reduce the amount of the increase in any particular year at their discretion, including a reduction to zero.
 
The ESPP is implemented through an offering every six months. According to the ESPP, eligible employees may use up to 15% of their salaries to purchase common stock up to an aggregate limit of $15 per participant for every six months plan. The price of an ordinary share purchased under the ESPP is equal to 85% of the lower of the fair market value of the ordinary share on the subscription date of each offering period or on the purchase date.
 
As of March 31, 2023, 738,876 shares of common stock had been purchased under the ESPP.
 
As of March 31, 2023, 3,411,504 shares of common stock were available for future issuance under the ESPP.
 
In accordance with ASC No. 718, the ESPP is compensatory and, as such, results in recognition of compensation cost.

 

F - 16


SOLAREDGE TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

 

(in thousands, except per share data)

 
e.
Stock-based compensation expenses:
 
The Company recognized stock-based compensation expenses related to all stock-based awards in the condensed consolidated statement of income for the three months ended March 31, 2023, and 2022, as follows:
 
   
Three Months Ended
March 31,
 
   
2023
   
2022
 
Cost of revenues
 
$
5,927
   
$
5,062
 
Research and development
   
17,209
     
14,985
 
Selling and marketing
   
8,079
     
6,701
 
General and administrative
   
8,020
     
7,359
 
Total stock-based compensation expenses
 
$
39,235
   
$
34,107
 
 
For the three months ended March 31, 2023, the Company capitalized stock-based compensation expenses in the amount of $430 related to ERP implementation, which were included within other long-term assets in the condensed consolidated balance sheets and $405 related to inventory.
 
For the three months ended March 31, 2022, the Company did not capitalize any stock-based compensation expenses.
 
The total tax benefit associated with share-based compensation for the three months ended March 31, 2023 and 2022 was $4,197 and $3,478, respectively. The tax benefit realized from share-based compensation for three months ended March 31, 2023 and 2022 was $2,842 and $2,927, respectively.
 
As of March 31, 2023, there were total unrecognized compensation expenses in the amount of $335,864 related to non-vested equity-based compensation arrangements granted. These expenses are expected to be recognized during the period from April 1, 2023 through February 28, 2027.

 

F - 17


SOLAREDGE TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

 

(in thousands, except per share data)

 

NOTE 12:     COMMITMENTS AND CONTINGENT LIABILITIES

a. Guarantees:

As of March 31, 2023, contingent liabilities exist regarding guarantees in the amounts of $5,876, and $1,899 in respect of office rent lease agreements and customs and other transactions, respectively.

b. Contractual purchase obligations:

The Company has contractual obligations to purchase goods and raw materials. These contractual purchase obligations relate to inventories and other purchase orders, which cannot be canceled without penalty. In addition, the Company acquires raw materials or other goods and services, including product components, by issuing authorizations to its suppliers to purchase materials based on its projected demand and manufacturing needs.

As of March 31, 2023, the Company had non-cancelable purchase obligations totaling approximately $1,617,376, out of which the Company recorded a provision for loss in the amount of $8,052.

As of March 31, 2023, the Company had contractual obligations for capital expenditures totaling approximately $121,347. These commitments reflect purchases of automated assembly lines and other machinery related to the Company’s general manufacturing process and mainly to its plans to establish manufacturing capabilities in the United States.

c.  Legal claims:

From time to time, the Company may be involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss. These accruals are reviewed at least quarterly and adjusted to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular matter.

In September 2018, the Company’s German subsidiary, SolarEdge Technologies GmbH, received a complaint filed by competitor SMA Solar Technology AG (“SMA”). The complaint, filed in the District Court Düsseldorf, Germany, alleges that SolarEdge's 12.5kW - 27.6kW inverters infringed on two of the plaintiff’s patents. SMA asserted a value in dispute of EUR 5.5 million (approximately $5,983) for both patents. The Company challenged the validity of both patents and the first patent was invalidated and SMA’s appeal on the matter was denied in January 2023. In August 2021, the German Patent Court rendered SMA's second patent invalid, and this invalidity has been appealed by SMA and a hearing is pending. The Company believes that it has meritorious defenses to these claims and intends to vigorously defend against the remaining lawsuit.

On July 28, 2022, the Company was served with complaints filed by Ampt LLC in the International Trade Commission (the “Commission”) pursuant to Section 337 of the Tariff Act of 1930, as amended, in the District Court for the District of Delaware alleging patent infringement against the Company and its subsidiary SolarEdge Technologies Ltd. On October 24, 2022, the complaint filed in the District Court of Delaware was administratively stayed until the Commission's action is resolved. The Company believes that it has meritorious defenses to the complaints and intend to vigorously defend against them.

As of March 31, 2023, an immaterial amount for legal claims was recorded in accrued expenses and other current liabilities.

 

F - 18


SOLAREDGE TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

 

(in thousands, except per share data)

 

NOTE 13:       ACCUMULATED OTHER COMPREHENSIVE LOSS
 
The following table summarizes the changes in accumulated balances of other comprehensive gain (loss), net of taxes:
 
 
   
Three Months Ended March 31,
 
   
2023
   
2022
 
Unrealized gains (losses) on available-for-sale marketable securities
           
Beginning balance
 
$
(25,449
)
 
$
(4,709
)
Revaluation
   
7,570
     
(12,721
)
Tax on revaluation
   
(1,471
)
   
2,471
 
Other comprehensive income (loss) before reclassifications
   
6,099
     
(10,250
)
Reclassification
   
107
     
844
 
Tax on reclassification
   
(29
)
   
(100
)
Losses reclassified from accumulated other comprehensive income
   
78
     
744
 
Net current period other comprehensive income (loss)
   
6,177
     
(9,506
)
Ending balance
 
$
(19,272
)
 
$
(14,215
)
Unrealized gains (losses) on cash flow hedges
               
Beginning balance
 
$
(1,761
)
 
$
874
 
Revaluation
   
(2,196
)
   
(1,337
)
Tax on revaluation
   
139
     
159
 
Other comprehensive loss before reclassifications
   
(2,057
)
   
(1,178
)
Reclassification
   
1,840
     
565
 
Tax on reclassification
   
(114
)
   
(67
)
Losses reclassified from accumulated other comprehensive loss
   
1,726
     
498
 
Net current period other comprehensive loss
   
(331
)
   
(680
)
Ending balance
 
$
(2,092
)
 
$
194
 
Foreign currency translation adjustments on intra-entity transactions that are of a long-term investment in nature
               
Beginning balance
 
$
(37,960
)
 
$
(17,420
)
Revaluation
   
(10,800
)
   
(6,983
)
Ending balance
 
$
(48,760
)
 
$
(24,403
)
Unrealized gains (losses) on foreign currency translation
               
Beginning balance
 
$
(7,939
)
 
$
(6,064
)
Revaluation
   
859
     
(1,579
)
Ending balance
 
$
(7,080
)
 
$
(7,643
)
Total
 
$
(77,204
)
 
$
(46,067
)

 

F - 19


SOLAREDGE TECHNOLOGIES INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  (Unaudited)

 

(in thousands, except per share data)

 

The following table summarizes the reclassifications from "Accumulated other comprehensive loss" into the statement of income:
 
Details about Accumulated Other Comprehensive
Loss Components
 
Three Months Ended
March 31,
 
Affected Line Item in the Statement of Income
   
2023
   
2022
   

Available-for-sale marketable securities

             
   
$
(107
)
 
$
(844)
 
Financial income (expense), net
     
29
     
100
 
Income taxes
   
$
(78
)
 
$
(744)
 
Total, net of income taxes

Cash flow hedges

                 
     
(212
)
   
(67
)
Cost of revenues
     
(1,129
)
   
(338
)
Research and development
     
(225
)
   
(71
)
Sales and marketing
     
(274
)
   
(89
)
General and administrative
   
$
(1,840
)
 
$
(565)
 
Total, before income taxes
     
114
     
67
 
Income taxes
     
(1,726
)
   
(498
)
Total, net of income taxes
Total reclassifications for the period
 
$
(1,804
)
 
$
(1,242)
   
 
NOTE 14:       OTHER OPERATING INCOME
 
In the three months ended March 31, 2023, the Company recorded a gain from sale of property, plant and equipment and other assets in the amount of $1,434.

 

NOTE 15:       INCOME TAXES
 
The effective tax rate for the three months ended March 31, 2023, and 2022 was 17.5% and 27.1%, respectively.
 
The lower tax rate in the current quarter compared to the first quarter of 2022 is mainly due to the fact that the Company's income before tax, most of which is subject to tax rates lower than the US statutory rate, increased. Conversely, the IRC Section 174 R&D capitalization, and other expenses not recognized for GILTI purposes, did not increase in the same proportion.
 
As of